The economic and health recovery of countries in the Asia-Pacific region from the pandemic is hinged on the rapid and equitable deployment of safe and effective COVID-19 vaccines. However, in the initial years of the COVID-19 vaccine roll-out, highly unequal distribution of vaccines occurred...

The COVID-19 pandemic has highlighted both the strengths and weaknesses of national, regional, and global vaccine research and development (R&D) systems. Translating public and private R&D efforts into effective vaccines in a timely manner requires not only sufficient financial and scientific...

The coronavirus disease (COVID-19) pandemic has highlighted the crucial role of vaccines in public health management and economic recovery. Its worldwide impact has raised national security concerns and implications on health policies, particularly on Asia Pacific countries' readiness to cope...

The COVID-19 pandemic re-emphasized the role of vaccines in prevention and control of outbreaks and infectious diseases, but not all countries are able to produce them. Limited domestic capacities combined with other bottlenecks have often resulted in vaccine stockouts in many countries. In this...

The global health crisis that came to be known as the COVID-19 pandemic and started to sweep across the world in early 2020 revealed many vulnerabilities in the economic, social, and political fabric underpinning what much of the world had come to accept as normal. In ways that we are still...

Vaccines against the coronavirus disease (COVID-19) have provided hope for containing the pandemic, but there are challenging obstacles to international transport and logistics of the new vaccines and vaccine inputs needed for manufacturing. This study identifies key barriers in the Asia-Pacific...

Timely and equitable access to vaccines and other health technologies is vital in effectively responding to pandemics and treating other communicable diseases. This paper shows how countries might overcome real or purported intellectual property (IP) barriers to regional COVID-19 vaccine...

There have been many important innovations in the landscape of vaccine development for neglected and emerging infectious diseases, such as the launch of public-private product development partnerships (PDPs). However, there is still a gap in funding the development of such vaccines, especially...